Abstract:
Background: The evaluation of new predictors of negative coronary remodeling after angioplasty remains an adequate approach of interventional
cardiology in the diagnosis and prognosis of in-stent restenosis (ISR). Previously we have demonstrated on a murine model of atherosclerosis that
extracellular RNA (eRNA) increases proportionally to vascular injury progression, and a first activation of the blood RNAase is changed by its steady
quantitative decline, a reason that suggests a plausible role of eRNA in coronary neointima hyperplasia.
Material and methods: This article is aimed at the study of eRNA amount in a tissue pattern of a stent with restenosis as well as its correlation with
such inflammatory predictors as macrophage number and TNF-alpha expression. Using the techniques of confocal microscopy and immunohistochemistry
we have first proved that eRNA level significantly increases in the coronary wall of segments with ISR (the specimens have been taken postmortem from
19 patients exposed to angioplasty).
Results: The rise in the assay has been closely correlated to restenosis degree, and in muscular media it has been 2-4 times beyond the control range
estimated in the adjacent coronary segment without negative vascular remodeling. In the restenosis zone eRNA has risen by about 130% from minimal
to severe ISR. Moreover, its level has been found markedly increased earlier also comparatively to the control pattern: by 62% in moderate and 128% in
severe ISR. A key disclosed evidence is that eRNA is positively correlated with TNF-alpha level (r = +0.88) and the number of macrophages (r = +0.84),
whereas the last is notably enhanced depending on ISR progression.
Conclusions: The obtained outcomes result in 2 opportunities: 1. eRNA may be a feasible predictor of negative coronary remodeling, facilitating
the prognosis of ISR risk; 2. eRNA may be singled out as a factor involved in the pathogenesis of neointima formation and hyperplasia due to its relation
to the inflammatory process.
Description:
Department of Interventional Cardiology, Institute of Cardiology, Chisinau, the Republic of Moldova